Programmed Death-Ligand 1 as a Regulator of Tumor Progression and Metastasis

Programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) immune checkpoint has long been implicated in modeling antitumor immunity; PD-1/PD-L1 axis inhibitors exert their antitumor effects by relieving PD-L1-mediated suppression on tumor-infiltrating T lymphocytes. However, recent st...

Descripción completa

Detalles Bibliográficos
Autores principales: Vathiotis, Ioannis A., Gomatou, Georgia, Stravopodis, Dimitrios J., Syrigos, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160779/
https://www.ncbi.nlm.nih.gov/pubmed/34065396
http://dx.doi.org/10.3390/ijms22105383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160779/
https://www.ncbi.nlm.nih.gov/pubmed/34065396
http://dx.doi.org/10.3390/ijms22105383

Ejemplares similares